Kirenol Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Differentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector T Cells

Lignende værker

• Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
  af: Ma, Ke, et al.
  Udgivet: (2016)
• Th1, Th17 and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes
  af: Jäger, Anneli, et al.
  Udgivet: (2009)
• Deficiency of Thrombonspondin-1 Reduces Th17 Differentiation and Attenuates Experimental Autoimmune Encephalomyelitis
  af: Yang, Kaiyong, et al.
  Udgivet: (2009)
• BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
  af: Zhou, Xiaohui, et al.
  Udgivet: (2011)
• Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
  af: Matthew Cummings, et al.
  Udgivet: (2018-01-01)